Article

A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records

2022-12-16

Abstract excerpt

<h4>Objectives</h4> The identification of novel uses for existing drug therapies has the potential to provide a rapid, low-cost approach to drug (re)discovery. In the current study we developed and tested a genetically-informed drug-repurposing pipeline for diabetes management. <h4>Design</h4> We developed and tested a genetically-informed drug-repurposing pipeline for diabetes management. This approach mapped gen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0dd147ea-d7be-54f0-91c3-36f15d07a37c
DOI: 10.1101/2022.12.14.22283414

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A genetically supported drug repurposing pipeline for diabetes treatment using electronic health recordsDOI 10.1101/2022.12.14.22283414Read

A Genetics-guided Integrative Framework for Drug Repurposing: Identifying Anti-hypertensive Drug Telmisartan for Type 2 DiabetesSemantic proximity Read

Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.Semantic proximity Read

Human genetics as a model for target validation: finding new therapies for diabetes.Semantic proximity Read

Using genome-wide association results to identify drug repurposing candidatesSemantic proximity Read

Calcium channel blockers as drug repurposing candidates for gestational diabetes: Mining large scale genomic and electronic health records data to repurpose medications.Semantic proximity Read

Harnessing the Power of Electronic Health Records and Genomics for Drug Discovery.Semantic proximity Read

Leveraging Genetic Correlations to Prioritize Drug Groups for Repurposing in Type 2 DiabetesSemantic proximity Read

Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related TraitsSemantic proximity Read

Pharmacogenetics: Opportunities for the All of Us Research Program and Other Large Data Sets to Advance the FieldSemantic proximity Read

A genomic-led strategy to anticipate drug safety effectsSemantic proximity Read

A genomic-led strategy to anticipate drug safety effects.Semantic proximity Read

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 DiabetesSemantic proximity Read